Impact of Neuropsychological Evaluation on Epilepsy Treatment

Epilepsy Clinical Trial

Official title:

Impact of Neuropsychological Evaluation on Epilepsy Treatment

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03202082
• Other study ID #: Satisfaction after Evaluation
• Status: Recruiting
• Phase: Phase 2
• First received: June 26, 2017
• Last updated: June 26, 2017
• Start date: July 1, 2015
• Est. completion date: June 30, 2018

Study information

• Verified date: June 2017
• Source: University of South Florida
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The present study aims to expand the evidence base of neuropsychological services in the context of medical management of epilepsy, examining whether treatment outcome and patient satisfaction with medical care are significantly improved when neuropsychological evaluation is included as an additional component of medical care within a comprehensive epilepsy center. All participants will complete an initial survey and a follow-up survey regarding views towards their epilepsy treatment. Participants will be randomized into one of two groups. One group will be given a neuropsychological battery in addition to the survey. The primary study hypothesis is that the addition of neuropsychological services to treatment-as-usual will result in significant improvements in (a) satisfaction with medical care, (b) patient perceived treatment outcome, and (c) physician-rated medical compliance. The secondary hypothesis is that participants who undergo neuropsychological evaluation will be generally satisfied with their experience with neuropsychological services.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: June 30, 2018
• Est. primary completion date: June 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

• 18 years of age or older

• experiencing some degree of epilepsy-related symptoms, but not of such severity as to preclude them from being able to provide consent or undergo neuropsychological assessment (requiring extended inpatient treatment, severely aphasic, or MMSE score < 25)

Exclusion Criteria:

• Previously undergone neuropsychological testing

• Currently pursuing surgical treatment for epilepsy

Related Conditions & MeSH terms

• Epilepsy

Intervention

Behavioral:
• Neuropsychological testing
Neuropsychological testing evaluates various aspects of a participants cognitive ability as well as mood.

Locations

Country	Name	City	State
United States	University of South Florida	Tampa	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Epilepsy Outcome Study Survey	A brief questionnaire regarding the participants views on their epilepsy treatment	2-4 months